The challenges and pitfalls of reporting on health research

With findings and recommendations constantly being updated, where does media coverage fit in?

That was the question asked recently by Boston Magazine. Almost every day, media outlets report on new and innovative health and medical studies, yet as time passes, some of that “new” information is updated and changed. Some conclusions change naturally as knowledge develops; others were likely reached haphazardly in the “publish or perish” environment of academia. 

The question, then, becomes whether covering new studies is a service to the audience, or a hindrance.

Read more at the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.